Skip to content
WeighLab
Menu
Ranked #8 · Grade BEditorial review

Hims & Hers review

Nationwide reach and a slick app at a mid-market semaglutide price — but an undisclosed tirzepatide price leaves part of the value equation blank.

Visit Hims & Hers Editorial review — no commercial relationship.
Semaglutide
$199/mo
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

The Index scorecard

Hims & Hers scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month80/100
Price Transparency80/100
Nationwide Access95/100
Formulation Options78/100
Clinical Oversight84/100
Contract Flexibility82/100

Where the value is

  • Nationwide
  • Slick app experience
  • Semaglutide priced up front for modeling

The tradeoffs

  • Tirzepatide pricing not consistently disclosed
  • Compounded supply has drawn industry-wide regulatory scrutiny

The bottom line

Best for: People who want a familiar, app-driven consumer brand and only need semaglutide. Nationwide reach and a slick app at a mid-market semaglutide price — but an undisclosed tirzepatide price leaves part of the value equation blank.

Ranked #8 of 9 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 8 other providers we've modeled, in Cost-Efficiency Index order.

Pricing, states and verification reflect Hims & Hers's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Hims & Hers's site. Not medical advice; see our disclosure.

← Back to the value leaderboard